Ignite Creation Date:
2025-12-25 @ 12:04 AM
Ignite Modification Date:
2026-02-24 @ 8:25 AM
Study NCT ID:
NCT05455658
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-24
First Post:
2022-06-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
STEMVAC in Patients With Early Stage Triple Negative Breast Cancer
Sponsor:
University of Washington
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Anatomic Stage IB Breast Cancer AJCC v8 | View |
| None | Anatomic Stage II Breast Cancer AJCC v8 | View |
| None | Anatomic Stage IIA Breast Cancer AJCC v8 | View |
| None | Anatomic Stage IIB Breast Cancer AJCC v8 | View |
| None | Anatomic Stage III Breast Cancer AJCC v8 | View |
| None | Anatomic Stage IIIA Breast Cancer AJCC v8 | View |
| None | Anatomic Stage IIIB Breast Cancer AJCC v8 | View |
| None | Anatomic Stage IIIC Breast Cancer AJCC v8 | View |
| None | Prognostic Stage IB Breast Cancer AJCC v8 | View |
| None | Prognostic Stage II Breast Cancer AJCC v8 | View |
| None | Prognostic Stage IIA Breast Cancer AJCC v8 | View |
| None | Prognostic Stage IIB Breast Cancer AJCC v8 | View |
| None | Prognostic Stage III Breast Cancer AJCC v8 | View |
| None | Prognostic Stage IIIA Breast Cancer AJCC v8 | View |
| None | Prognostic Stage IIIB Breast Cancer AJCC v8 | View |
| None | Prognostic Stage IIIC Breast Cancer AJCC v8 | View |
| None | Triple-Negative Breast Carcinoma | View |
Keywords: